Sign in / Join Now
ETFs & Funds
Alan Robert Ross
CF To 2017: Why PVCT Can Afford To Complete Phase III Trials Without Further Dilution. $
Add a reply...
Latest StockTalks »
people get PVCT breaking news and analysis by email alert.
Get email alerts on PVCT »
Provectus Biopharmaceuticals, Inc.
Get latest price
From other sites
Provectus Biopharmaceuticals Will Hold A Business Update Conference Call Thursday - January 5, 2017 At 9 A.m. (EST)
at TheStreet (Jan 3, 2017)
Provectus Biopharmaceuticals Terminates Peter Culpepper As Interim CEO And COO
at TheStreet (Dec 28, 2016)
Provectus Biopharmaceuticals Announces Two Poster Presentations On PV-10 For Liver Tumors
at TheStreet (Dec 22, 2016)
(Graphic: Business Wire)
at TheStreet (Dec 8, 2016)
Provectus Biopharmaceuticals, Inc. Announces Notification Of NYSE MKT Listing Deficiency
at TheStreet (Nov 30, 2016)